GSA Capital Partners LLP Increases Stock Position in Trupanion, Inc. (NASDAQ:TRUP)

GSA Capital Partners LLP lifted its holdings in shares of Trupanion, Inc. (NASDAQ:TRUPFree Report) by 51.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,487 shares of the financial services provider’s stock after acquiring an additional 3,554 shares during the period. GSA Capital Partners LLP’s holdings in Trupanion were worth $440,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of TRUP. 8 Knots Management LLC lifted its holdings in Trupanion by 87.0% in the first quarter. 8 Knots Management LLC now owns 1,297,485 shares of the financial services provider’s stock valued at $35,824,000 after acquiring an additional 603,775 shares during the period. Renaissance Technologies LLC purchased a new stake in shares of Trupanion during the 2nd quarter worth about $4,739,000. Hosking Partners LLP acquired a new position in Trupanion during the 2nd quarter worth approximately $3,523,000. Marshall Wace LLP lifted its position in Trupanion by 11.9% during the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after acquiring an additional 116,496 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in shares of Trupanion by 160.2% in the 2nd quarter. SG Americas Securities LLC now owns 71,012 shares of the financial services provider’s stock valued at $2,088,000 after purchasing an additional 43,720 shares in the last quarter.

Trupanion Trading Down 2.2 %

Shares of NASDAQ TRUP opened at $51.82 on Thursday. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90. The firm has a market capitalization of $2.19 billion, a PE ratio of -161.94 and a beta of 1.69. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The business has a 50-day moving average price of $48.58 and a two-hundred day moving average price of $38.86.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same period last year, the company posted ($0.10) EPS. As a group, analysts predict that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The trade was a 6.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,124 shares of company stock worth $482,981 in the last three months. 5.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on TRUP. Piper Sandler upped their price target on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Northland Securities lifted their target price on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Stifel Nicolaus increased their price target on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 23rd. Bank of America increased their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Finally, Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $44.67.

View Our Latest Stock Report on Trupanion

Trupanion Company Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUPFree Report).

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.